Renzo Steffano Valle Farfán, Enver Vantroi Palacios Ordoñez, Ysabel Lozano Rodas, Stefano Alessandro Valle Farfán
{"title":"Compromiso del parénquima pulmonar secundaria a la inyección subcutánea de geles de silicona: reporte de caso","authors":"Renzo Steffano Valle Farfán, Enver Vantroi Palacios Ordoñez, Ysabel Lozano Rodas, Stefano Alessandro Valle Farfán","doi":"10.24265/horizmed.2023.v23n1.10","DOIUrl":null,"url":null,"abstract":"Pulmonary parenchymal involvement secondary to the subcutaneous injection of silicone gels is an unusual condition which occurs more frequently in women aged between 22 and 55 years. Although different theories have been put forward about its etiology, it is unknown and the condition may cause local and systemic complications and even have a fatal outcome. Few cases have been reported in South America and there is no report of this unique entity in Peru. We present the case of a previously healthy 28-year-old male transgender patient who, after an illegal subcutaneous injection of silicone gels in the gluteal region given by a non-healthcare professional, showed progressive respiratory distress and stabbing chest pain of approximately 7 out of 10 on the pain scale within the first 24 hours. Upon admission to the emergency room, respiratory failure was objectively evidenced since the patient had an oxygen saturation of 72 % at a FiO2 of 21 %, as well as pulmonary parenchymal involvement both in the CT scan and chest X-ray with signs highly suggestive of this pathology. Using a SARS-CoV-2 RNA real-time RT-PCR test performed on a respiratory specimen, COVID pneumonia, immunodeficiency disorders and pulmonary embolism were ruled out. Since there is no standard treatment, the patient was given relevant support measures such as the administration of supplemental oxygen at a low flow rate by binasal cannula, intravenous systemic corticosteroids and antibiotic therapy, thus achieving good progress with resolution of the initial clinical presentation. Then, after 10 days of intrahospital treatment, the patient was discharged.Copyright © La revista. Publicado por la Universidad de San Martin de Porres, Peru.","PeriodicalId":396953,"journal":{"name":"Horizonte Médico (Lima)","volume":"644 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Horizonte Médico (Lima)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24265/horizmed.2023.v23n1.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
皮下注射硅胶凝胶继发性肺实质损伤:病例报告
继发于皮下注射硅酮凝胶的肺实质受累是一种罕见的情况,多见于22至55岁的女性。虽然其病因有不同的说法,但尚不清楚,该病可引起局部和全身并发症,甚至致命。南美洲报告的病例很少,秘鲁也没有这一独特实体的报告。我们报告了一个先前健康的28岁男性变性患者,在由非医疗保健专业人员在臀部区域非法皮下注射硅凝胶后,在最初的24小时内表现出进行性呼吸窘迫和刺痛,疼痛等级约为7 / 10。在进入急诊室时,客观地证明了呼吸衰竭,因为患者的氧饱和度为72%,FiO2为21%,并且CT扫描和胸部x线检查显示肺实质受累,高度提示这种病理。通过对呼吸道标本进行SARS-CoV-2 RNA实时RT-PCR检测,排除了COVID -肺炎、免疫缺陷疾病和肺栓塞。由于无标准治疗,患者给予相应的支持措施,如双鼻插管低流速补氧、全身静脉注射糖皮质激素、抗生素治疗等,取得了良好的进展,初步临床表现得到缓解。经过10天的院内治疗,患者出院。版权所有©La revista。秘鲁圣马丁大学。
本文章由计算机程序翻译,如有差异,请以英文原文为准。